Genomic Studies Utilize Scale As Clinical Utility Catches Up
An innovative system for monitoring chromosomal fragility and copy number alterations in particularly lethal tumours...
Novavax COVID-19 Vaccine Is Fourth US Option Now Available
As infections in the U.S. continue to be at high levels, the Food and Drug...
Alice – a tireless hero in the fight against Covid-19
Aspen successfully expands CMO activities with filling equipment from Syntegon
At first sight, anesthetics and vaccines...
New Drug Mix From ICR And The Royal Marsden Shows Promise
The findings of a phase 1 trial examining a medication mixture targeting multiple mutant variants...
Citius Pharma selects global CRO, Biorasi to help expand phase 3 Mino-Lok trial to...
Citius Pharmaceuticals, Inc., a late-stage biopharmaceutical company, announced that it has selected Biorasi, LLC (Biorasi),...
Oragenics Engages KBI Biopharma to Support Development of Intranasal COVID-19 Vaccine Candidate NT-CoV2-1
Oragenics, Inc. announced it has entered into an agreement with KBI Biopharma, Inc. for the...
WuXi ATU Announces Launch of TESSA Technology to Improve Scalability and Accessibility of Cell...
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the launch...
Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule
Midatech Pharma PLC, a drug delivery technology company, announced an extension of its existing R&D...
Vibalogics Completes Major Milestone in $50M Cuxhaven Facility Expansion with New 500L Manufacturing Line
Vibalogics, a leading virotherapy contract development and manufacturing organization (CDMO) focused on the production of...
Orbit Discovery and WuXi AppTec sign agreement to access peptide discovery and optimisation technologies
Orbit Discovery (Orbit), a ground-breaking peptide discovery company is pleased to announce the commencement of...